PANACEABIO.BOPANACEABIO.BOBSE
Loading
EBITDA Over TimeContracting
Percentile Rank13
3Y CAGR-20.5%
5Y CAGR-20.0%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
-20.5%/yr
vs -27.8%/yr prior
5Y CAGR
-20.0%/yr
Consistent
Acceleration
+7.3pp
Accelerating
Percentile
P13
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
4 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$282.80M-8.0%
2025$307.40M-26.0%
2024$415.37M-26.3%
2023$563.65M-96.6%
2022$16.74B+1834.8%
2021$865.18M+91.8%
2020$451.09M-78.3%
2019$2.07B+120.4%
2018$941.25M-16.7%
2017$1.13B-